Literature DB >> 2348838

Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration.

H M Furneaux1, M K Rosenblum, J Dalmau, E Wong, P Woodruff, F Graus, J B Posner.   

Abstract

Paraneoplastic cerebellar degeneration is a rare syndrome that occurs in patients with gynecologic cancer and is characterized by widespread loss of Purkinje cells. To determine whether Purkinje-cell antigens are selectively expressed in the tumors of patients with the syndrome, we examined tumor tissue from 10 patients whose serum contained anti-Purkinje-cell (anti-Yo) antibodies. The origins of the cancers were the breast (five patients), ovary (three), endometrium (one), and fallopian tube (one). We used as controls tumor tissue from 11 patients with ovarian cancer and 10 patients with breast cancer who were neurologically normal. Using immunohistochemical and Western blot analysis, we found that Purkinje-cell antigens were expressed in all the tumors from the 10 patients with paraneoplastic cerebellar degeneration but in none of the tumors from the 21 neurologically normal patients. When IgG from patients with paraneoplastic cerebellar degeneration was affinity-purified to cerebellar Purkinje-cell antigen, immunohistochemical analysis showed that it reacted specifically with the tumor tissue from those patients. We conclude that in patients with paraneoplastic cerebellar degeneration, the anti-Yo antibody results from an immune response to neural antigens expressed by the gynecologic tumors in the patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2348838     DOI: 10.1056/NEJM199006283222604

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  48 in total

1.  Pursuing an occult carcinoma in a patient with subacute cerebellar degeneration and anticerebellar antibodies. Need for vigorous follow-up.

Authors:  J E Greenlee; H R Brashear; K A Jaeckle; A Geleris; K Jordan
Journal:  West J Med       Date:  1992-02

2.  Long-term efficiency of intravenously administered immunoglobulin in anti-Yo syndrome with paraneoplastic cerebellar degeneration.

Authors:  J Schessl; M Schuberth; P Reilich; P Schneiderat; N Strigl-Pill; M C Walter; B Schlotter-Weigel; B Schoser
Journal:  J Neurol       Date:  2010-12-21       Impact factor: 4.849

3.  Subacute motor neuronopathy associated with hepatocellular carcinoma.

Authors:  Nilda Turgut; Hakan Karagöl; Yahya Celik; Kazim Uygun; Aylin Reyhani
Journal:  J Neurooncol       Date:  2006-12-20       Impact factor: 4.130

Review 4.  Cancer and systemic sclerosis: novel insights into pathogenesis and clinical implications.

Authors:  Ami A Shah; Antony Rosen
Journal:  Curr Opin Rheumatol       Date:  2011-11       Impact factor: 5.006

5.  Effects of in vivo and in vitro administration of neuro-Behcet's disease IgG.

Authors:  Ece Erdağ; Ceren Şahin; Cem İsmail Küçükali; Sinem Bireller; Melike Küçükerden; Murat Kürtüncü; Recai Türkoğlu; Bedia Cakmakoglu; Erdem Tüzün; Feyza Arıcıoğlu
Journal:  Neurol Sci       Date:  2017-02-21       Impact factor: 3.307

6.  IFN-γ is a therapeutic target in paraneoplastic cerebellar degeneration.

Authors:  Lidia Yshii; Béatrice Pignolet; Emilie Mauré; Mandy Pierau; Monika Brunner-Weinzierl; Oliver Hartley; Jan Bauer; Roland Liblau
Journal:  JCI Insight       Date:  2019-04-04

7.  Impact of Neuro-Behçet Disease Immunoglobulin G on Neuronal Apoptosis.

Authors:  Murat Giriş; Sinem Bireller; Cem İsmail Küçükali; Haşmet Hanağasi; Sevgin Değirmencioğlu; Erdem Tüzün
Journal:  Noro Psikiyatr Ars       Date:  2016-12-08       Impact factor: 1.339

8.  Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen.

Authors:  Eric Lancaster; Meizan Lai; Xiaoyu Peng; Ethan Hughes; Radu Constantinescu; Jeffrey Raizer; Daniel Friedman; Mark B Skeen; Wolfgang Grisold; Akio Kimura; Kouichi Ohta; Takahiro Iizuka; Miguel Guzman; Francesc Graus; Stephen J Moss; Rita Balice-Gordon; Josep Dalmau
Journal:  Lancet Neurol       Date:  2009-12-02       Impact factor: 44.182

Review 9.  Central nervous system toxicity from cancer treatment.

Authors:  Terri Armstrong; Mark R Gilbert
Journal:  Curr Oncol Rep       Date:  2004-01       Impact factor: 5.075

10.  Paraneoplastic cerebellar degeneration with a circulating antibody against neurons and non-neuronal cells.

Authors:  H Tomimoto; J M Brengman; T Yanagihara
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.